Biopharma Innovation Models for Gulf Region in the Era of Globalisation

Abstract

Biopharmaceutical is the most upcoming segment of the pharmaceutical industry as the use of biotechnology has the potential to provide cures for the most life threatening and difficult ailments. At the same time for biopharma innovation, factors such as increasing costs, high continuous funding, and risk funding are of increasing concern for the emerging economies. This chapter measures the strength of biopharma innovation indicators in Gulf Cooperation Council (GCC) and explores the potential biopharma innovation models for gulf countries.